Quarterly report pursuant to Section 13 or 15(d)

Collaboration and Research Arrangements (Tables)

v3.22.2.2
Collaboration and Research Arrangements (Tables)
9 Months Ended
Sep. 30, 2022
Collaborative Arrangement Disclosure [Abstract]  
Schedule of Change in Accounts Receivable, Contract Assets and Liabilities

The following table presents the changes in accounts receivable, contract assets and liabilities for the nine months ended September 30, 2022 (in thousands):

 

 

Balance at
December 31, 2021

 

 

Additions

 

 

Deductions

 

 

Balance at September 30, 2022

 

Accounts receivable and contract assets:

 

 

 

 

 

 

 

 

 

 

 

 

Billed receivables from collaboration partners

 

$

 

 

$

8,288

 

 

$

(8,288

)

 

$

 

Unbilled receivables from collaboration partners

 

 

2,979

 

 

 

7,476

 

 

 

(8,684

)

 

 

1,771

 

Total accounts receivable and contract assets

 

$

2,979

 

 

$

15,764

 

 

$

(16,972

)

 

$

1,771

 

Contract liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Deferred revenue - Incyte

 

$

1,268

 

 

$

 

 

$

(1,228

)

 

$

40

 

Deferred revenue - GBT

 

 

8,913

 

 

 

199

 

 

 

(7,527

)

 

 

1,585

 

Total contract liabilities

 

$

10,181

 

 

$

199

 

 

$

(8,755

)

 

$

1,625